Pharmaceutical composition intended to be administred to nasal mucosa

• 收藏
• 分享

专利权人:

Teijin Pharma Limited

发明人:

Maruo, Susumu,Nagano, Atsuhiro,Nonaka, Yuko,Furukawa, Ryo

申请号：

AU2016346823

公开号：

AU2016346823A1

申请日:

2016.10.28

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention addresses the problem of providing nasal drops which can achieve high absorption of oxytocin, which is a peptide hormone, an acid addition salt of oxytocin or a derivative of oxytocin or the acid addition salt through a nasal mucosa and which has less concerns about safety. The present invention is a pharmaceutical composition intended to be administered to a nasal mucosa, characterized by comprising oxytocin, an acid addition salt of oxytocin or a derivative of oxytocin or the acid addition salt and a carboxyvinyl polymer and having an osmotic pressure ratio of less than 1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/